• Lockheed Martin recently reported fourth-quarter 2025 results with sales rising to US$20,321 million and full-year 2025 revenue reaching US$75,048 million, alongside issuing 2026 guidance for sales of US$77,500 million to US$80,000 million and diluted EPS of US$29.35 to US$30.25.
• The company also signed a multi-year framework agreement with the U.S. Department of War to ramp up THAAD interceptor output and PAC-3 production, underpinning a record backlog of about US$194 billion and supporting large-scale investments in new manufacturing capacity.
• We’ll now look at how this expanded THAAD production framework and upbeat 2026 guidance shape Lockheed Martin’s broader investment narrative.

Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

What Is Lockheed Martin's Investment Narrative?

To own Lockheed Martin, you need to be comfortable tying your capital to long-lived defense programs, heavy government exposure and a balance sheet that leans on debt to generate very high reported returns on equity. The latest quarter and 2026 guidance reinforce that story: a record US$194 billion backlog, multi‑year frameworks to ramp THAAD and PAC‑3 output, and capital going into new facilities like the Munitions Acceleration Center all point to contracted work supporting the near-term revenue line and management’s earnings targets. The stock’s sharp move higher after the announcement suggests the market sees these agreements as meaningful catalysts rather than background noise. At the same time, higher production commitments and capex can magnify existing risks around execution, margin pressure and dependence on future U.S. government funding decisions.

However, investors should also factor in how rising leverage and big build‑outs could cut both ways. Lockheed Martin's shares are on the way up, but they could be overextended by 7%. Uncover the fair value now.

Exploring Other Perspectives

Twenty two Simply Wall St Community fair value estimates for Lockheed Martin span roughly US$398 to US$605 per share, underscoring how differently investors are weighing the new missile frameworks, backlog strength and funding risk.

Explore 22 other fair value estimates on Lockheed Martin - why the stock might be worth as much as $605.00!

Build Your Own Lockheed Martin Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Lockheed Martin research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Lockheed Martin research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lockheed Martin's overall financial health at a glance.

Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.